Evidence map›Paper›PMID 26259597›Full record

ArticleRadiation oncology (London, England)2015

Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines.

Gisela Wohlleben, Agmal Scherzad, Antje Güttler, Dirk Vordermark, Sebastian Kuger, Michael Flentje, Buelent Polat

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Matricellular proteins: Potential biomarkers in head and neck cancer.Journal of cell communication and signaling · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2018
    Article
  6. Article
  7. Review
  8. Implications of Hypoxia in Breast Cancer Metastasis to Bone.International journal of molecular sciences · 2016
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gisela WohllebenDepartment of Radiation Oncology, University hospital Wuerzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany. Wohlleben_G@ukw.de.
Agmal ScherzadDepartment of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University hospital Wuerzburg, Wuerzburg, Germany. Scherzad_A@ukw.de.
Antje GüttlerDepartment of Radiotherapy, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany. guettler.antje@gmail.com.
Dirk VordermarkDepartment of Radiotherapy, Martin-Luther-University Halle-Wittenberg, Halle, Saale, Germany. dirk.vordermark@uk-halle.de.
Sebastian KugerDepartment of Radiation Oncology, University hospital Wuerzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany. sebastian.kuger@helmholtz-muenchen.de.
Michael FlentjeDepartment of Radiation Oncology, University hospital Wuerzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany. Flentje_M@ukw.de.
Buelent PolatDepartment of Radiation Oncology, University hospital Wuerzburg, Josef-Schneider-Straße 11, 97080, Würzburg, Germany. polat_b@ukw.de.
Universitätsklinikum Würzburg · DEMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTumor hypoxia is a known risk factor for reduced response to radiotherapy. The evaluation of noninvasive methods for the detection of hypoxia is therefore of interest. Osteopontin (OPN) has been discussed as an endogenous hypoxia biomarker. It is overexpressed in many cancers and is involved in tumor progression and metastasis.

methodsTo examine the influence of hypoxia and irradiation on osteopontin expression we used different cell lines (head and neck cancer (Cal27 and FaDu) and glioblastoma multiforme (U251 and U87)). Cells were treated with hypoxia for 24 h and were then irradiated with doses of 2 and 8 Gy. Osteopontin expression was analyzed on mRNA level by quantitative real-time RT-PCR (qPCR) and on protein level by western blot. Cell culture supernatants were evaluated for secreted OPN by ELISA.

resultsHypoxia caused an increase in osteopontin protein expression in all cell lines. In Cal27 a corresponding increase in OPN mRNA expression was observed. In contrast the other cell lines showed a reduced mRNA expression under hypoxic conditions. After irradiation OPN mRNA expression raised slightly in FaDu and U87 cells while it was reduced in U251 and stable in Cal27 cells under normoxia. The combined treatment (hypoxia and irradiation) led to a slight increase of OPN mRNA after 2 Gy in U251 (24 h) and in U87 (24 and 48 h) cell lines falling back to base line after 8 Gy. This effect was not seen in Cal27 or in FaDu cells. Secreted OPN was detected only in the two glioblastoma cell lines with reduced protein levels under hypoxic conditions. Again the combined treatment resulted in a minor increase in OPN secretion 48 hours after irradiation with 8 Gy.

conclusionOsteopontin expression is strongly modulated by hypoxia and only to a minor extent by irradiation. Intracellular OPN homeostasis seems to vary considerably between cell lines. This may explain the partly conflicting results concerning response prediction and prognosis in the clinical setting.

Indexed as

Biomarkers, TumorBlotting, WesternCell HypoxiaCell Line, TumorEnzyme-Linked Immunosorbent AssayGlioblastomaHead and Neck NeoplasmsHumansOsteopontinReal-Time Polymerase Chain ReactionBiomarkers, TumorOsteopontin

Identifiers

PMID26259597
PMCPMC4554368
OpenAlexW1903903412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.